Literature DB >> 32169351

Management of Intraoperative Failure of Anterolateral Thigh Flap Transplantation in Head and Neck Reconstruction.

Chang Liu1, Panchun Li1, Jiang Liu1, Yuming Xu1, Hanjiang Wu2, Zhaojian Gong3.   

Abstract

PURPOSE: The aim of the present study was to explore the remedial methods for the failure of anterolateral thigh (ALT) flap transplantation and to evaluate the efficacy of these methods in head and neck reconstruction. PATIENTS AND METHODS: We performed a retrospective study of 11 patients who experienced intraoperative failure of ALT flap transplantation in head and neck reconstruction that was successfully salvaged with the same donor site. The cause of flap failure, corresponding management, and complications at the donor and recipient sites were recorded.
RESULTS: All 11 patients were men with an average age of 56.5 years. Of the 11 cases of flap preparation or transplantation failure, 1 was caused by arterial thromboembolism (after vascular anastomosis), 4 by perforator injury, 4 by mistaken perforator ligation, 1 by perforator thromboembolism, and 1 by the perforator deep penetration in muscle. All were successfully rescued with the same donor site, including harvest of another ALT flap with the other perforator in 5 patients, elevation of an anteromedial thigh flap in 4, and perforator anastomosis in 2 patients.
CONCLUSIONS: With effective remedial methods for the failure of flap transplantation and their great versatility, the use of ALT flaps is a good choice for reconstruction of head and neck defects.
Copyright © 2020 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32169351     DOI: 10.1016/j.joms.2020.02.010

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  1 in total

1.  Reconstruction of Complex Lateral Skull Base Defects After Oral Cancer Resection With Individualized Anterolateral Thigh Flap.

Authors:  Zhaojian Gong; Shanshan Zhang; Chang Chen; Yuan Zhi; Moxin Zi
Journal:  Front Oncol       Date:  2021-09-22       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.